
|Podcasts|February 20, 2023
Pharmacy Focus: Oncology Edition - Pharmacists Play Key Role in Non–Small Cell Lung Cancer
Pharmacists can be involved in all aspects of care, from deciding treatment plans to educating patients, and in the growing role of oral treatments.
Advertisement
This month, we spoke with Jennifer Martin, PharmD, BCOP, a hematology-oncology pharmacist with the Allegheny Health Network. Martin said pharmacists can be involved in all aspects of care, from deciding treatment plans to educating patients, and in the growing role of oral treatments.
Interested in learning more? Check out these related articles:
FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer Medicaid Patients With NSCLC May Be Undertreated With Life-Prolonging Targeted Therapies Expert Discusses PD-1 Inhibitors as Treatment of NSCLC New Digital Tool Provides Resources for Patients With Small Cell Lung Cancer and Their Caregivers
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nerandomilast Receives FDA Approval for Idiopathic Pulmonary Fibrosis
2
Study Shows Infliximab Biosimilar is Safe in Patients Undergoing RA Treatment
3
Dexamethasone-Sparing Regimen Offers Safer Option for Frail Patients With MM
4
Pneumococcal Polysaccharide Vaccination Does Not Reduce Rates of Cardiovascular Events
5